These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 16009948

  • 1. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
    Ohrling K, Edler D, Hallström M, Ragnhammar P, Blomgren H.
    J Clin Oncol; 2005 Aug 20; 23(24):5628-34. PubMed ID: 16009948
    [Abstract] [Full Text] [Related]

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Aug 20; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 3. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar 01; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S, Matsuoka H, Ishikawa T, Maeda K, Shimomura R, Inada K, Tsutsumi Y.
    Jpn J Clin Oncol; 2004 Oct 01; 34(10):594-601. PubMed ID: 15591457
    [Abstract] [Full Text] [Related]

  • 6. Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil.
    Fernández-Contreras ME, Jiménez De Ayala B, García De Paredes ML, Velasco A, Majano PL, Palacios J, Gamallo C.
    Int J Oncol; 2004 Oct 01; 25(4):877-85. PubMed ID: 15375535
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH, Kwon HC, Oh SY, Lee DM, Lee S, Lee JH, Roh MS, Kim DC, Park KJ, Choi HJ, Kim HJ.
    Am J Clin Oncol; 2009 Feb 01; 32(1):38-43. PubMed ID: 19194123
    [Abstract] [Full Text] [Related]

  • 8. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study.
    Kawano K, Yanagisawa S, Kusukawa J, Sunagawa H, Shiba R, Goto M, Shinohara M, Fukuda J, Oishi M, Ikemura K, Takahashi T, Sugihara K, Inokuchi T, Mimura T, Goto H.
    Int J Oral Maxillofac Surg; 2006 Mar 01; 35(3):258-64. PubMed ID: 16280240
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
    Trocha SD, Saha SS, Wiese D, Thompson J, Morton DL, Bilchik AJ.
    Am Surg; 2003 Oct 01; 69(10):918-22. PubMed ID: 14570375
    [Abstract] [Full Text] [Related]

  • 10. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S, Lopes A, Soares FA, Rossi BM, Ferreira FO, Nakagawa WT, Carvalho AL, Filho WJ.
    Eur J Surg Oncol; 2005 Oct 01; 31(8):863-8. PubMed ID: 15923105
    [Abstract] [Full Text] [Related]

  • 11. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E, Cuatrecases M, Martínez-Iniesta M, Navarro M, Vilardell F, Guinó E, Pareja L, Figueras A, Molleví DG, Serrano T, de Oca J, Peinado MA, Moreno V, Germà JR, Capellá G, Villanueva A.
    J Clin Oncol; 2006 Apr 01; 24(10):1603-11. PubMed ID: 16575011
    [Abstract] [Full Text] [Related]

  • 12. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
    Edler D, Glimelius B, Hallström M, Jakobsen A, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H.
    J Clin Oncol; 2002 Apr 01; 20(7):1721-8. PubMed ID: 11919227
    [Abstract] [Full Text] [Related]

  • 13. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A, International Breast Cancer Study Group.
    Cancer; 2003 Apr 01; 97(7):1591-600. PubMed ID: 12655514
    [Abstract] [Full Text] [Related]

  • 14. Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial.
    Sakamoto J, Hamashima H, Suzuki H, Ito K, Mai M, Saji S, Fukushima M, Matsushita Y, Nakazato H.
    Oncol Rep; 2003 Apr 01; 10(5):1081-90. PubMed ID: 12883662
    [Abstract] [Full Text] [Related]

  • 15. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.
    Edler D, Hallström M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H.
    Clin Cancer Res; 2000 Apr 01; 6(4):1378-84. PubMed ID: 10778966
    [Abstract] [Full Text] [Related]

  • 16. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H, Yamada H, Shirakawa K, Nakada H, Ohsawa T, Takeuchi I, Okada N, Yokoyama M, Inokuma S, Suzuki T, Odaka A, Hoshino T, Murata N, Hashimoto D, Itoyama S, Mori T, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2003 Oct 01; 30(11):1621-6. PubMed ID: 14619479
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H.
    Clin Cancer Res; 2000 Feb 01; 6(2):488-92. PubMed ID: 10690528
    [Abstract] [Full Text] [Related]

  • 18. Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.
    Karlberg M, Ohrling K, Edler D, Hallström M, Ullén H, Ragnhammar P.
    Anticancer Res; 2010 Feb 01; 30(2):645-51. PubMed ID: 20332484
    [Abstract] [Full Text] [Related]

  • 19. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
    Aschele C, Debernardis D, Lonardi S, Bandelloni R, Casazza S, Monfardini S, Gallo L.
    J Clin Oncol; 2004 Sep 15; 22(18):3758-65. PubMed ID: 15365072
    [Abstract] [Full Text] [Related]

  • 20. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
    Berglund A, Edler D, Molin D, Nordlinder H, Graf W, Glimelius B.
    Anticancer Res; 2002 Sep 15; 22(6B):3653-9. PubMed ID: 12552972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.